Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
22.42
-0.54 (-2.33%)
Jun 3, 2026, 11:20 AM EDT - Market open
Damora Therapeutics Employees
Damora Therapeutics had 7 employees as of December 31, 2025. The number of employees increased by 2 or 40.00% compared to the previous year.
Employees
7
Change (1Y)
2
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$33,584,143
Market Cap
1.38B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | 2 | 40.00% |
| Dec 31, 2024 | 5 | -8 | -61.54% |
| Dec 31, 2023 | 13 | -32 | -71.11% |
| Dec 31, 2022 | 45 | 5 | 12.50% |
| Dec 31, 2021 | 40 | 12 | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Immatics | 711 |
| Immunocore Holdings | 524 |
| Vir Biotechnology | 367 |
| KalVista Pharmaceuticals | 275 |
| Precigen | 160 |
| Innoviva | 159 |
| Inhibrx Biosciences | 110 |
DMRA News
- 2 days ago - Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 days ago - Wedbush bullish on Damora Therapeutics, initiates with an Outperform - TheFly
- 6 days ago - Damora Therapeutics initiated with an Outperform at Wedbush - TheFly
- 21 days ago - Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 21 days ago - Damora Therapeutics Slides: Corporate presentation - Filings
- 22 days ago - Damora Therapeutics Quarterly report: Q1 2026 - Filings
- 22 days ago - Damora Therapeutics Earnings release: Q1 2026 - Filings
- 5 weeks ago - Damora Therapeutics Proxy statement: Proxy filing - Filings